Growing clinical data support the use of transcatheter therapies for significant mitral valve
disease. Currently, edge-to-edge repair is the transcatheter treatment of choice, but many …

Mitral transcatheter therapies represent the treatment of choice for all patients deemed
unsuitable for cardiac surgery. So far, the largest clinical experience has been limited to …

Transcatheter mitral interventions has been developed to address an unmet clinical need
and may be an alternative therapeutic option to surgery with the intent to provide …

Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left
untreated, it confers a poorer prognosis. Catheter-based repair therapies face some …

The emergence of transcatheter aortic valve replacement (TAVR) has segued the
development of transcatheter mitral valve (MV) repair devices. Transcatheter mitral valve …

Background: There are scarce data available on transcatheter mitral valve replacement
(TMVR), and these have been limited to procedural results, with no follow-up status …

De Backer et al Transcatheter Mitral Valve Replacement 401 increase overall efficacy. 11
However, for many patients MV repair will not be possible, and MV replacement will be …

Transcatheter mitral valve repair, particularly edge-to-edge leaflet repair, is a well-
established alternative for patients with severe primary mitral regurgitation (MR) considered …

The favorable outcomes achieved with modern mitral valve repair techniques redefined the
role of mitral valve replacement. Various international databases report a significant …

Background Transcatheter mitral valve replacement (TMVR) has emerged as an alternative
therapeutic option for the treatment of severe mitral regurgitation in patients with prohibitive …